Indokem sets September 24 AGM for director reappointments and RPT approvals
Indokem schedules 60th AGM for September 24, 2026, via video conferencing. Shareholders to approve reappointment of Managing Director Arupkumar Basu and Whole-time Director Manish M. Khatau. Revised remuneration for Manish M. Khatau totals ₹41.4 lakh annually plus perquisites. Related-party transactions worth ₹46 crore with Orchard Acres and ₹30 crore with Texcare Middle East LLC seek approval. FY25-26 net profit stands at ₹213 lakh on total income of ₹15,128 lakh.
*this image is generated using AI for illustrative purposes only.
Indokem Limited has scheduled its 60th Annual General Meeting (AGM) for Thursday, September 24, 2026, at 2:00 pm. The meeting will be conducted through video conferencing or other audio-visual means, with e-voting facilities available to shareholders on record as of September 17, 2026.
Governance and Directorship
The Board seeks shareholder approval for several key governance resolutions. Mrs. Asha Mahendra Khatau, a non-executive director, retires by rotation and offers herself for re-appointment. Additionally, shareholders are asked to approve the re-appointment of Mr. Arupkumar Basu as Managing Director for a three-year term commencing September 29, 2026. Mr. Basu, aged 71, requires special resolution approval under Section 196(3)(a) of the Companies Act, 2013.
The meeting will also address the re-appointment of Mr. Manish M. Khatau as Whole-time Director for three years starting March 1, 2027. Concurrently, shareholders must approve a revision in his remuneration effective April 1, 2026. The revised package includes a salary of ₹20.7 lakh per annum, city compensatory allowance of ₹17.22 lakh, gratuity of ₹99,360, and provident fund contributions of ₹2.48 lakh, totaling ₹41.4 lakh annually. Additional benefits include medical reimbursements, insurance premiums, club fees, a car with driver, and residential accommodation rent up to ₹6 lakh per month.
Related Party Transactions
Two significant related-party transactions require shareholder consent for FY27. The first involves Orchard Acres, a partnership firm in which promoter directors hold stakes. The proposed aggregate transaction value is ₹46 crore, covering purchases, sales, rent, and loans. This represents 27.16% of the company’s annual consolidated turnover of ₹169.39 crore for FY25-26.
The second transaction concerns Texcare Middle East LLC, a foreign step-down wholly-owned subsidiary. The company proposes to sell goods and services to Texcare with an aggregate value of ₹30 crore. This amount constitutes 17.71% of Indokem’s consolidated turnover for the preceding financial year. Both transactions are stated to be at arm’s length and in the ordinary course of business.
Financial Performance
For the financial year ended March 31, 2026, Indokem reported total income of ₹15,128 lakh. The company recorded a profit before depreciation and tax of ₹427 lakh, resulting in a net profit for the year of ₹213 lakh. The Board attributed previous profitability challenges to uncertain economic conditions, high inflation, and slow industrial growth, noting efforts to modernize facilities and expand capacity for value-added chemicals.
What the Numbers Show
Indokem’s reliance on related-party entities is significant relative to its scale. The combined proposed RPT value of ₹76 crore (₹46 crore with Orchard Acres and ₹30 crore with Texcare) amounts to approximately 44.8% of the company’s reported FY25-26 consolidated turnover of ₹169.39 crore. This concentration highlights the operational integration between Indokem and its promoter-linked trading firm, Orchard Acres, as well as its international distribution arm, Texcare.
Cost Audit Ratification
Shareholders will also ratify the remuneration of M/s. Y. S. Gokhale & Associates as Cost Auditors for FY26-27. The approved fee is ₹1.4 lakh plus applicable taxes and out-of-pocket expenses.
Historical Stock Returns for Indokem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.49% | +1.24% | +1.24% | +1.24% | +1.24% | +1.24% |
How might the significant concentration of related-party transactions, comprising nearly 45% of turnover, impact Indokem's valuation multiples and investor confidence in future quarters?
What specific operational synergies or cost-saving measures are expected from the expanded capacity for value-added chemicals to offset the recent profitability challenges?
Could the re-appointment of the 71-year-old Managing Director under special resolution provisions signal potential leadership transition risks or governance scrutiny from institutional investors?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
